(HealthDay)—Approval of the anti-clotting drug Xarelto (rivaroxaban) has been expanded by the U.S. Food and Drug Administration to include treating deep vein thrombosis (DVT) or pulmonary embolism.
Nov 05, 2012
not rated yet | 0
Hardly anyone succumbs to the bubonic plague these days, but US health authorities on Friday approved a new treatment for it and other forms of the potentially deadly bacterial infection.
Apr 27, 2012
not rated yet | 1